EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management

Alexandra N McMahon, Juan Pablo de Rivero Vaccari iD, Isildinha M Reis, Cristiane Takita iD, Jean L Wright, Yan Guo iD, Jennifer J Hu

Cancers · 28.03.2026 · 18 (7) · 1100

DOI: 10.3390/cancers18071100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.03.2026. Verfasst von Alexandra N McMahon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Health, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adjuvant RT remains a standard therapy for breast cancer, reducing recurrence risk and improving survival; however, it can also induce side effects, including pain. Inflammasome-related biomarkers, such as interleukin-18 (IL-18), play a role in inflammation-mediated pain, and we hypothesize that IL-18 may serve as a potential biomarker for breast cancer RT-induced pain.

Methods

The association between IL-18 and pain was assessed among breast cancer patients receiving adjuvant RT. Plasma IL-18 protein concentration was quantified before and after RT using Ella SimplePlex technology (Biotechne). Clinically relevant pain outcomes included pre-RT pain (pain score ≥ 4), post-RT pain (pain score ≥ 4), and RT-related pain (increase in pain from

Schlagwörter

Stichwörter der Autor:innen

IL-18breast cancerinflammasomepainradiotherapy

Autor:innen und Institutionen

  • Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC 27514, USA.

ORCID-Profile: Juan Pablo de Rivero Vaccari, Cristiane Takita, Yan Guo

Förderung

  • NCI NIH HHS
  • National Institute of Health
  • National Institutes of Health

Zitieren

APA

McMahon, A. N., de Rivero Vaccari, J. P., Reis, I. M., Takita, C., Wright, J. L., Guo, Y., & Hu, J. J. (2026). Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management. Cancers, 18(7), 1100. https://doi.org/10.3390/cancers18071100

Vancouver

McMahon AN, de Rivero Vaccari JP, Reis IM, Takita C, Wright JL, Guo Y, et al. Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management. Cancers. 2026;18(7):1100. doi:10.3390/cancers18071100

BibTeX
@article{McMahon2026,
  author = {McMahon, Alexandra N and de Rivero Vaccari, Juan Pablo and Reis, Isildinha M and Takita, Cristiane and Wright, Jean L and Guo, Yan and Hu, Jennifer J},
  title = {Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1100},
  doi = {10.3390/cancers18071100}
}
Kostenlos starten →